This work is licensed under the Creative Commons Attribution 4.0 International License.
El Houat Y, Massard C, Quillien V, de Crevoisier R, Castelli J. Meta-analysis and critical review: association between radio-induced lymphopenia and overall survival in solid cancers. Adv Radiat Oncol 2022; 8: 101038. doi: 10.1016/j.adro.2022.101038El HouatYMassardCQuillienVde CrevoisierRCastelliJ.Meta-analysis and critical review: association between radio-induced lymphopenia and overall survival in solid cancers. Adv Radiat Oncol2022; 8: 101038. doi: 10.1016/j.adro.2022.101038Open DOISearch in Google Scholar
Duque-Santana V, López-Campos F, Martin-Martin M, Valero M, Zafra-Martín J, Couñago F, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic factors in locally advanced rectal cancer. Oncology 2023; 101: 349-57. doi: 10.1159/000526450Duque-SantanaVLópez-CamposFMartin-MartinMValeroMZafra-MartínJCouñagoFNeutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic factors in locally advanced rectal cancer. Oncology2023; 101: 349-57. doi: 10.1159/000526450Open DOISearch in Google Scholar
Pham TN, Coupey J, Thariat J, Valable S. Impact of circulating lymphocyte kinetics following radiotherapy on patient survival: a model-based meta-analysis. Comput Biol Med 2025; 186: 109702. doi: 10.1016/j.comp-biomed.2025.109702PhamTNCoupeyJThariatJValableS.Impact of circulating lymphocyte kinetics following radiotherapy on patient survival: a model-based meta-analysis. Comput Biol Med2025; 186: 109702. doi: 10.1016/j.comp-biomed.2025.109702Open DOISearch in Google Scholar
Ellsworth SG. Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors. Adv Radiat Oncol 2018; 3: 512-9. doi: 10.1016/j.adro.2018.08.014EllsworthSG.Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors. Adv Radiat Oncol2018; 3: 512-9. doi: 10.1016/j.adro.2018.08.014Open DOISearch in Google Scholar
Prades-Sagarra E, Yaromina A, Dubois LJ. Understanding the impact of radiation-induced lymphopenia: preclinical and clinical research perspectives. Clin Transl Radiat Oncol 2024; 49: 100852. doi: 10.1016/j.ctro.2024.100852Prades-SagarraEYarominaADuboisLJ.Understanding the impact of radiation-induced lymphopenia: preclinical and clinical research perspectives. Clin Transl Radiat Oncol2024; 49: 100852. doi: 10.1016/j.ctro.2024.100852Open DOISearch in Google Scholar
Terrones-Campos C, Ledergerber B, Vogelius IR, Specht L, Helleberg M, Lundgren J. Lymphocyte count kinetics, factors associated with the end-of-radiation-therapy lymphocyte count, and risk of infection in patients with solid malignant tumors treated with curative-intent radiation therapy. Int J Radiat Oncol Biol Phys 2019; 105: 812-23. doi: 10.1016/j.ijrobp.2019.07.013Terrones-CamposCLedergerberBVogeliusIRSpechtLHellebergMLundgrenJ.Lymphocyte count kinetics, factors associated with the end-of-radiation-therapy lymphocyte count, and risk of infection in patients with solid malignant tumors treated with curative-intent radiation therapy. Int J Radiat Oncol Biol Phys2019; 105: 812-23. doi: 10.1016/j.ijrobp.2019.07.013Open DOISearch in Google Scholar
Tuta M, Boc N, Brecelj E, Omejc M, Anderluh F, Ermenc AS, et al. Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia. Radiol Oncol 2019; 53: 465-72. doi: 10.2478/raon-2019-0046TutaMBocNBreceljEOmejcMAnderluhFErmencASTotal neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia. Radiol Oncol2019; 53: 465-72. doi: 10.2478/raon-2019-0046Open DOISearch in Google Scholar
Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, et al. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO/AIO-12 randomized clinical trial. JAMA Oncol 2022; 8: e215445. doi: 10.1001/jamaoncol.2021.5445FokasESchlenska-LangeAPolatBKlautkeGGrabenbauerGGFietkauRChemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO/AIO-12 randomized clinical trial. JAMA Oncol2022; 8: e215445. doi: 10.1001/jamaoncol.2021.5445Open DOISearch in Google Scholar
Verheij FS, Omer DM, Williams H, Lin ST, Qin LX, Buckley JT, et al. Longterm results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. J Clin Oncol 2024; 42: 500-6. doi: 10.1200/JCO.23.01208VerheijFSOmerDMWilliamsHLinSTQinLXBuckleyJTLongterm results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial. J Clin Oncol2024; 42: 500-6. doi: 10.1200/JCO.23.01208Open DOISearch in Google Scholar
Bedrikovetski S, Traeger L, Seow W, Dudi-Venkata NN, Selva-Nayagam S, Penniment M, et al. oncological outcomes and response rate after total neoadjuvant therapy for locally advanced rectal cancer: a network metaanalysis comparing induction vs. consolidation chemotherapy vs. standard chemoradiation. Clin Colorectal Cancer 2024; 23: 326-36.e9. doi: 10.1016/j. clcc.2024.06.001BedrikovetskiSTraegerLSeowWDudi-VenkataNNSelva-NayagamSPennimentMoncological outcomes and response rate after total neoadjuvant therapy for locally advanced rectal cancer: a network metaanalysis comparing induction vs. consolidation chemotherapy vs. standard chemoradiation. Clin Colorectal Cancer2024; 23: 326-36.e9. doi: 10.1016/j. clcc.2024.06.001Open DOISearch in Google Scholar
Fokas E, Williams H, Diefenhardt M, Lin S, Qin LX, Piso P, et al. Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials. Eur J Cancer 2024; 210: 114291. doi: 10.1016/j.ejca.2024.114291FokasEWilliamsHDiefenhardtMLinSQinLXPisoPChemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials. Eur J Cancer2024; 210: 114291. doi: 10.1016/j.ejca.2024.114291Open DOISearch in Google Scholar
Fokas E, Allgäuer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, et al. Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. J Clin Oncol 2019; 37: 3212-22. doi: 10.1200/JCO.19.00308.FokasEAllgäuerMPolatBKlautkeGGrabenbauerGGFietkauRRandomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12. J Clin Oncol2019; 37: 3212-22. doi: 10.1200/JCO.19.00308.Open DOISearch in Google Scholar
Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 2022; 40: 2546-2556. doi: 10.1200/JCO.22.00032Garcia-AguilarJPatilSGollubMJKimJKYuvalJBThompsonHMOrgan preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol2022; 40: 2546-2556. doi: 10.1200/JCO.22.00032Open DOISearch in Google Scholar
Verheij FS, Omer DM, Lin ST, Yuval JB, Thompson HM, Kim JK, et al. Compliance and toxicity of total neoadjuvant therapy for rectal cancer: a secondary analysis of the OPRA Trial. Int J Radiat Oncol Biol Phys 2024; 118: 115-123. doi: 10.1016/j.ijrobp.2023.07.043VerheijFSOmerDMLinSTYuvalJBThompsonHMKimJKCompliance and toxicity of total neoadjuvant therapy for rectal cancer: a secondary analysis of the OPRA Trial. Int J Radiat Oncol Biol Phys2024; 118: 115-123. doi: 10.1016/j.ijrobp.2023.07.043Open DOISearch in Google Scholar
Zimmermann M, Richter A, Weick S, Exner F, Mantel F, Diefenhardt M, et al. Acute toxicities of patients with locally advanced rectal cancer treated with intensified chemoradiotherapy within the CAO/ARO/AIO-12 trial: comparing conventional versus VMAT planning at a single center. Sci Rep 2022; 12: 21263. doi: 10.1038/s41598-022-25647-8ZimmermannMRichterAWeickSExnerFMantelFDiefenhardtMAcute toxicities of patients with locally advanced rectal cancer treated with intensified chemoradiotherapy within the CAO/ARO/AIO-12 trial: comparing conventional versus VMAT planning at a single center. Sci Rep2022; 12: 21263. doi: 10.1038/s41598-022-25647-8Open DOISearch in Google Scholar
Nanos C, Koukourakis IM, Mulita A, Avgousti R, Kouloulias V, Zygogianni A, et al. Lymphopenia induced by different neoadjuvant chemo-radiotherapy schedules in patients with rectal cancer: bone marrow as an organ at risk. Curr Oncol 2024; 31: 5774-88. doi: 10.3390/curroncol31100429NanosCKoukourakisIMMulitaAAvgoustiRKoulouliasVZygogianniALymphopenia induced by different neoadjuvant chemo-radiotherapy schedules in patients with rectal cancer: bone marrow as an organ at risk. Curr Oncol2024; 31: 5774-88. doi: 10.3390/curroncol31100429Open DOISearch in Google Scholar
Corbeau A, Kuipers SC, de Boer SM, Horeweg N, Hoogeman MS, Godart J, et al. Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review. Radiother Oncol 2021; 164: 128-37. doi: 10.1016/j.radonc.2021.09.009CorbeauAKuipersSCde BoerSMHorewegNHoogemanMSGodartJCorrelations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review. Radiother Oncol2021; 164: 128-37. doi: 10.1016/j.radonc.2021.09.009Open DOISearch in Google Scholar
Dovšak T, Ihan A, Didanovič V, Kansky A, Ihan Hren N. Influence of surgical treatment and radiotherapy of the advanced intraoral cancers on complete blood count, body mass index, liver enzymes and leukocyte CD64 expression. Radiol Oncol 2009; 43: 282-92. doi: 10.2478/v10019-009-0034-8DovšakTIhanADidanovičVKanskyAIhan HrenN.Influence of surgical treatment and radiotherapy of the advanced intraoral cancers on complete blood count, body mass index, liver enzymes and leukocyte CD64 expression. Radiol Oncol2009; 43: 282-92. doi: 10.2478/v10019-009-0034-8Open DOISearch in Google Scholar
Dovšak T, Ihan A, Didanovič V, Kansky A, Verdenik M, Hren NI. Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer. BMC Cancer 2018; 18: 235. doi: 10.1186/s12885-018-4136-9DovšakTIhanADidanovičVKanskyAVerdenikMHrenNI.Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer. BMC Cancer2018; 18: 235. doi: 10.1186/s12885-018-4136-9Open DOISearch in Google Scholar
Zhu J, Lian J, Xu B, Pang X, Ji S, Zhao Y, et al. Neoadjuvant immunotherapy for colorectal cancer: right regimens, right patients, right directions? Front Immunol 2023; 14: 1120684. doi: 10.3389/fimmu.2023.1120684ZhuJLianJXuBPangXJiSZhaoYNeoadjuvant immunotherapy for colorectal cancer: right regimens, right patients, right directions?Front Immunol2023; 14: 1120684. doi: 10.3389/fimmu.2023.1120684Open DOISearch in Google Scholar
Li Y, Pan C, Gao Y, Zhang L, Ji D, Cui X, et al. Total neoadjuvant therapy with PD-1 blockade for high-risk proficient mismatch repair rectal cancer. JAMA Surg 2024; 159: 529-37. doi: 10.1001/jamasurg.2023.7996LiYPanCGaoYZhangLJiDCuiXTotal neoadjuvant therapy with PD-1 blockade for high-risk proficient mismatch repair rectal cancer. JAMA Surg2024; 159: 529-37. doi: 10.1001/jamasurg.2023.7996Open DOISearch in Google Scholar
Grossman SA, Ellsworth S, Campian J, Wild AT, Herman JM, Laheru D, et al. Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors. J Natl Compr Canc Netw 2015; 13: 1225-31. doi: 10.6004/jnccn.2015.0151GrossmanSAEllsworthSCampianJWildATHermanJMLaheruDSurvival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors. J Natl Compr Canc Netw2015; 13: 1225-31. doi: 10.6004/jnccn.2015.0151Open DOISearch in Google Scholar
Huang W, Dang J, Li Y, Cui HX, Lu WL, Jiang QF. Effect of pelvic bone marrow sparing intensity modulated radiation therapy on acute hematologic toxicity in rectal cancer patients undergoing chemo-radiotherapy. Front Oncol 2021; 11: 646211. doi: 10.3389/fonc.2021.646211HuangWDangJLiYCuiHXLuWLJiangQF.Effect of pelvic bone marrow sparing intensity modulated radiation therapy on acute hematologic toxicity in rectal cancer patients undergoing chemo-radiotherapy. Front Oncol2021; 11: 646211. doi: 10.3389/fonc.2021.646211Open DOISearch in Google Scholar
Mahantshetty U, Krishnatry R, Chaudhari S, Kanaujia A, Engineer R, Chopra S, et al. Comparison of 2 contouring methods of bone marrow on CT and correlation with hematological toxicities in non-bone marrowsparing pelvic intensity-modulated radiotherapy with concurrent cisplatin for cervical cancer. Int J Gynecol Cancer 2012; 22: 1427-34. doi: 10.1097/IGC.0b013e3182664b46MahantshettyUKrishnatryRChaudhariSKanaujiaAEngineerRChopraSComparison of 2 contouring methods of bone marrow on CT and correlation with hematological toxicities in non-bone marrowsparing pelvic intensity-modulated radiotherapy with concurrent cisplatin for cervical cancer. Int J Gynecol Cancer2012; 22: 1427-34. doi: 10.1097/IGC.0b013e3182664b46Open DOISearch in Google Scholar
